Other

Noncontrolling interests in subsidiaries

CVS Health Noncontrolling interests in subsidiaries decreased by 7.7% to $168.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 1.2%, from $170.00M to $168.00M. Over 5 years (FY 2020 to FY 2025), Noncontrolling interests in subsidiaries shows a downward trend with a -11.6% CAGR.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryMarket Position
SignalContext dependent
VolatilityModerate
First reportedQ4 2025
Last reportedQ1 2026

How to read this metric

Fluctuations reflect changes in the profitability of partially owned subsidiaries or changes in ownership percentages.

Detailed definition

This represents the portion of equity in a subsidiary that is not attributable to the parent company. It reflects the ow...

Peer comparison

Common in mining companies that operate through joint ventures or regional subsidiaries.

Metric ID: other_minority_interest

Historical Data

19 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$321.00M$310.00M$306.00M$310.00M$322.00M$328.00M$300.00M$198.00M$276.00M$173.00M$175.00M$182.00M$181.00M$162.00M$170.00M$181.00M$172.00M$182.00M$168.00M
QoQ Change-3.4%-1.3%+1.3%+3.9%+1.9%-8.5%-34.0%+39.4%-37.3%+1.2%+4.0%-0.5%-10.5%+4.9%+6.5%-5.0%+5.8%-7.7%
YoY Change+0.3%+5.8%-2.0%-36.1%-14.3%-47.3%-41.7%-8.1%-34.4%-6.4%-2.9%-0.5%-5.0%+12.3%-1.2%
Range$162.00M$328.00M
CAGR-13.4%
Avg YoY Growth-12.1%
Median YoY Growth-5.0%

Frequently Asked Questions

What is CVS Health's noncontrolling interests in subsidiaries?
CVS Health (CVS) reported noncontrolling interests in subsidiaries of $168.00M in Q4 2025.
How has CVS Health's noncontrolling interests in subsidiaries changed year-over-year?
CVS Health's noncontrolling interests in subsidiaries decreased by 1.2% year-over-year, from $170.00M to $168.00M.
What is the long-term trend for CVS Health's noncontrolling interests in subsidiaries?
Over 5 years (2020 to 2025), CVS Health's noncontrolling interests in subsidiaries has grown at a -11.6% compound annual growth rate (CAGR), from $312.00M to $168.00M.
What does noncontrolling interests in subsidiaries mean?
The share of a subsidiary's value that belongs to other investors rather than the parent company.